Search results for "Respiratory Physiology"

showing 10 items of 363 documents

PEST-domain-enriched tyrosine phosphatase and glucocorticoids as regulators of anaphylaxis in mice

2011

To cite this article: Obiri DD, Flink N, Maier JV, Neeb A, Maddalo D, Thiele W, Menon A, Stassen M, Kulkarni RA, Garabedian MJ, Barrios AM, Cato ACB. PEST-domain-enriched tyrosine phosphatase and glucocorticoids as regulators of anaphylaxis in mice. Allergy 2012; 67: 175–182. Abstract Background:  PEST-domain-enriched tyrosine phosphatase (PEP) is a protein tyrosine phosphatase exclusively expressed in hematopoietic cells. It is a potent negative regulator of T-cell receptor signalling that acts on receptor-coupled protein tyrosine kinases. PEST-domain-enriched tyrosine phosphatase is also expressed in mast cell and is positively regulated by glucocorticoids, but its function is unknown. In…

medicine.medical_specialtyeducationImmunologyDegranulationProtein tyrosine phosphataseBiologyImmunoglobulin EMast cellPTPN22Endocrinologymedicine.anatomical_structureInternal medicinecardiovascular systemmedicinebiology.proteinImmunology and AllergyPhosphorylationSignal transductionGlucocorticoidcirculatory and respiratory physiologymedicine.drugAllergy
researchProduct

Atrial natriuretic peptide secretion during development of the rat supraoptic nucleus

2009

Since a relationship between atrial natriuretic peptide and oxytocin was recently demonstrated in the heart (Gutkowska et al., 1997), the aim of this study was to determine whether a relationship between the two peptides is present also in the rat hypothalamus. For this purpose, we measured ANP-ontogeny in the rat hypothalamus immunohistochemically and compared it with oxytocin-ontogeny which we previously studied. The results showed that the ANP-peptide and mRNA-ANP start at the 18th day of the fetal life. Our earlier data for oxytocin in the rat hypothalamus showed that only mRNA-oxytocin appeared the 18th day of foetal life (Farina Lipari et al., 2001); thus, at the 18th day of foetal li…

medicine.medical_specialtyendocrine systemHistologyBiophysicsOxytocinSupraoptic nucleusAtrial natriuretic peptidePregnancyInternal medicinesupraopticMedicineAnimalsSecretionRNA MessengerRats Wistarlcsh:QH301-705.5FetusMessenger RNAbusiness.industryReverse Transcriptase Polymerase Chain ReactionnucleushypothalamicCell BiologyImmunohistochemistryRatsEndocrinologyOxytocinAnimals NewbornGene Expression Regulationlcsh:Biology (General)Hypothalamuscardiovascular systemFemalebusinessSupraoptic NucleusAtrial Natriuretic FactorCell Nucleolushormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologymedicine.drugEuropean Journal of Histochemistry
researchProduct

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis

2021

Abstract Aims Cardiac resynchronization therapy (CRT) is highly effective in dilated cardiomyopathy (DCM) patients with impaired left ventricular ejection fraction (LVEF) and left bundle block branch. In cardiac amyloidosis (CA) patients, left ventricular dysfunction and conduction defects are common, but the potential of CRT to improve cardiac remodelling and survival in this particular setting remains undefined. We investigated cardiovascular outcomes in CA patients after CRT implantation in terms of CRT echocardiographic response and major cardiovascular events (MACEs). Methods and results Our retrospective study included 47 CA patients implanted with CRT devices from January 2012 to Feb…

medicine.medical_specialtygenetic structuresmedicine.medical_treatmentPopulationCardiac resynchronization therapyHeart failureCardiac amyloidosisVentricular Function LeftInternal medicineImplantable cardioverter defibrillatormedicineHumansDiseases of the circulatory (Cardiovascular) systemcardiovascular diseaseseducationAgedRetrospective StudiesAged 80 and overeducation.field_of_studyCardiac resynchronization therapyEjection fractionbusiness.industryHazard ratioDilated cardiomyopathyStroke VolumeOriginal ArticlesAmyloidosismedicine.diseaseImplantable cardioverter-defibrillatorDefibrillators ImplantablePacemakerTreatment OutcomeCardiac amyloidosisHeart failureRC666-701Cardiologycardiovascular systemOriginal ArticleCardiology and Cardiovascular Medicinebusinesstherapeuticscirculatory and respiratory physiologyESC Heart Failure
researchProduct

Transcatheter Mitral Repair for Functional Mitral Regurgitation According to Left Ventricular Function: A Real-Life Propensity-Score Matched Study

2020

Background: Transcatheter mitral valve repair (TMVR) could improve survival in functional mitral regurgitation (FMR), but it is necessary to consider the influence of left ventricular ejection fraction (LVEF). Therefore, we compare the outcomes after TMVR with Mitraclip&reg

medicine.medical_specialtylcsh:Medicine030204 cardiovascular system & hematologyMitraclipArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineIn patient030212 general & internal medicinecardiovascular diseasesFunctional mitral regurgitationEjection fractionVentricular functionbusiness.industryMitraCliplcsh:RGeneral Medicinetranscatheterleft ventricular ejection FractionPropensity score matchingCardiologycardiovascular systemObservational studyTranscatheter mitral valve repairbusinesscirculatory and respiratory physiologyfunctional mitral regurgitationJournal of Clinical Medicine
researchProduct

Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?

2021

International journal of environmental research and public health : IJERPH 18(8), 4344 (2021). doi:10.3390/ijerph18084344

medicine.medical_specialtymasksHealth Toxicology and MutagenesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Respiratory impairmentPopulationcontraindicationsReviewRespiratory physiologyNoseAudiology03 medical and health sciences0302 clinical medicinesurgical maskmedicineHumansddc:610030212 general & internal medicineeducationPersonal protective equipmentN95 face maskNoseriskphysical exertionMoutheducation.field_of_studySARS-CoV-2hypoxiabusiness.industryRPublic Health Environmental and Occupational HealthCOVID-19MIES syndromehypercapniadyspneaSurgical maskmedicine.anatomical_structurepersonal protective equipmentadverse effectslong-term adverse effectshealth risk assessmentMedicineLong Term Adverse Effectsbusinessheadache030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

A Bifurcation with Surprise

2016

FFR was assessed after provisional stenting of a bifurcation stenosis in the proximal LAD in a very young patient. Pull-back demonstrated a good outcome after PCI, and it revealed the existence of an additional stenosis which, due to its very proximal location in the LAD, could not be seen at angiography. This case emphasizes the importance of performing FFR measurements during sustained hyperemia and using a slow pull-back technique.

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedia_common.quotation_subjectequipment and suppliesmedicine.diseaseStenosisSurprisesurgical procedures operativeInternal medicineConventional PCIAngiographycardiovascular systemmedicineCardiologycardiovascular diseasesGood outcomebusinessBifurcationcirculatory and respiratory physiologymedia_common
researchProduct

Clinical pharmacokinetics of atenolol — A review

1982

Atenolol is a hydrophilic betareceptor blocking drug, which is predominantly eliminated via the kidneys, only about 5% of the atenolol is metabolised by the liver. After oral administration atenolol is incompletely absorbed from the intestine, so about 50% of the beta blocker are finally biovailable. In plasma only 3% of atenolol are protein-bound. There exists a linear relationship between the atenolol plasma levels and the degree of beta blocking effect measured by inhibition of the exercise-induced tachycardia. No correlation was found between plasma levels of atenolol and blood pressure lowering activity of the drug. After oral administration elimination half life of atenolol is calcula…

medicine.medical_specialtymedicine.drug_classAdministration OralBiological AvailabilityRenal functionPharmacologyKidneyIntestinal absorptionPropanolaminesPharmacokineticsRenal DialysisOral administrationInternal medicinemedicineHumansDrug InteractionsPharmacology (medical)cardiovascular diseasesBeta blockerPharmacologyChemistryLiver DiseasesKidney metabolismAtenololKineticsEndocrinologyAtenololIntestinal AbsorptionInjections IntravenousKidney DiseasesBiological half-lifecirculatory and respiratory physiologymedicine.drugEuropean Journal of Drug Metabolism and Pharmacokinetics
researchProduct

Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure

2009

The presence of a reciprocal link between inflammation and oxidative/nitrosative stress has been postulated in chronic heart failure (CHF). We aimed to determine signs of nitrosative stress in serum/plasma of CHF patients. ELISA tests were used for quantification of serum/plasma levels of Nitrotyrosine (NT), H(2)O(2), total NO, nitrite (NO(2)(-)), myeloperoxidase (MPO), Tumor Necrosis Factor-alpha (TNFalpha) and pro-Brain Natriuretic Peptide (proBNP) in 66 CHF patients (9 in NYHA I, 34 NYHA II, 23 NYHA III) and in 14 age-matched healthy subjects. NT levels were higher in NYHA III CHF patients compared to NYHA II (p<0.05), NYHA I (p<0.03) and controls (p<0.02), whereas NO(2)(-) and total NO …

medicine.medical_specialtymedicine.drug_classInflammationSystemic inflammationGastroenterologyNITROSATIVE STRESSchemistry.chemical_compoundInternal medicineBlood plasmamedicineNatriuretic peptidecardiovascular diseasesOXIDATIVE STRESSEndothelial dysfunctionbiologybusiness.industryNitrotyrosinemedicine.diseasehumanitiesEndocrinologychemistryMyeloperoxidaseHeart failureENDOTHELIAL DYSFUNCTIONcardiovascular systembiology.proteinmedicine.symptomCardiology and Cardiovascular Medicinebusinesscirculatory and respiratory physiology
researchProduct

The QRS narrowing index for easy and early identification of responder to cardiac resynchronization therapy.

2013

The rationale for cardiac resynchronization therapy (CRT) in patients with heart failure (HF) is based on the possibility of inducing substantial left ventricular reverse remodeling. It is well known that some of these patients don't benefit from this therapy (the so-called non-responders) [1,2]. No better predictors of a positive answer to CRT than pre-CRT QRS duration (QRSd) were found [3,4]. The aim of our study was to identify a parameter for an easy and early identification of responders to CRT. In this regard, according to Rickard et al., we identified and observed QRS index (QI), as an expression of electrical remodeling after CRT, and its relation with anatomic reverse remodeling, e…

medicine.medical_specialtymedicine.medical_treatmentPopulationCardiac resynchronization therapyCardiac Resynchronization TherapyElectrocardiographyQRS complexPredictive Value of TestsInternal medicinemedicineHumanscardiovascular diseaseseducationHeart Failureeducation.field_of_studyIschemic cardiomyopathyEjection fractionVentricular RemodelingLeft bundle branch blockbusiness.industryAtrial fibrillationRight bundle branch blockmedicine.diseaseCardiac resynchronization therapy Heart failure ResponderTreatment OutcomeMultivariate Analysiscardiovascular systemCardiologyCardiology and Cardiovascular Medicinebusinesscirculatory and respiratory physiology
researchProduct

Respiratory Sinus Arrhythmia Mechanisms in Young Obese Subjects

2020

Autonomic nervous system (ANS) activity and imbalance between its sympathetic and parasympathetic components are important factors contributing to the initiation and progression of many cardiovascular disorders related to obesity. The results on respiratory sinus arrhythmia (RSA) magnitude changes as a parasympathetic index were not straightforward in previous studies on young obese subjects. Considering the potentially unbalanced ANS regulation with impaired parasympathetic control in obese patients, the aim of this study was to compare the relative contribution of baroreflex and non-baroreflex (central) mechanisms to the origin of RSA in obese vs. control subjects. To this end, we applied…

obesitymedicine.medical_specialtyRespiratory sinus arrhythmia obesity autonomic nervous system information decomposition multiscale analysisSupine position030204 cardiovascular system & hematologyBaroreflexlcsh:RC321-57103 medical and health sciences0302 clinical medicineInternal medicinemedicineHeart rate variabilityrespiratory sinus arrhythmiaYoung adultVagal tonelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal Researchbusiness.industryGeneral Neuroscienceautonomic nervous systemmultiscale analysismedicine.diseaseObesityAutonomic nervous systemBlood pressureSettore ING-INF/06 - Bioingegneria Elettronica E Informaticainformation decompositionCardiologybusiness030217 neurology & neurosurgeryNeurosciencecirculatory and respiratory physiologyFrontiers in Neuroscience
researchProduct